Table 1.
Return to work overall random effects pooled prevalence, according to the characteristics of the studies and the clinical and socio-professional characteristics of the patients.
| No. | RTW % [95%-CI] | I2 | pa | ||
|---|---|---|---|---|---|
| Recruitment date | < 2001 | 22 | 79.6 [74.4; 84.4] | 97.2 | 0.458 |
| ≥ 2001 | 21 | 82.7 [75.7; 88.8] | 98.8 | ||
| Disease definition | Clinical | 37 | 81.3 [75.8; 86.2] | 97.9 | 0.971 |
| ICD | 4 | 78.8 [57.5; 94.0] | 99.8 | ||
| Interview | 2 | 80.5 [74.9; 85.5] | 99.7 | ||
| Outcome definition | Self-reported | 36 | 83.9 [70.0; 94.0] | 96.7 | 0.610 |
| Not self-reported | 7 | 81.6 [75.2; 87.2] | 99.8 | ||
| NOS-scale score | 7 stars or more | 27 | 80.2 [67.3; 90.6] | 99.3 | 0.821 |
| < 7 stars | 16 | 85.2 [81.1; 88.9] | 97.9 | ||
| WHO region | International | 3 | 79.8 [73.0; 85.8] | 78.6 | 0.654 |
| Europe | 31 | 85.0 [62.3; 98.4] | 99.2 | ||
| Western Pacific | 5 | 81.9 [70.5; 91.0] | 98.9 | ||
| America | 2 | 82.2 [71.8; 90.7] | 67.0 | ||
| Eastern Mediterranean | 2 | 75.9 [59.6; 89.1] | 84.2 | ||
| Gender | Male | 11 | 64.4 [44.3; 82.3] | 99.6 | 0.336 |
| Female | 11 | 74.9 [62.8; 85.4] | 99.0 | ||
| Age | < 51 years | 6 | 82.0 [63.5; 95.0] | 96.6 | 0.387 |
| 51–53 years | 9 | 86.2 [73.4; 95.4] | 99.1 | ||
| 54 years and more | 7 | 65.3 [45.2; 83.0] | 98.2 | ||
| Education level | < High school | 7 | 85.6 [81.2; 89.6] | 87.6 | 0.085 |
| ≥ High school | 7 | 80.8 [67.1; 91.5] | 74.2 | ||
| LVEF | < 40% | 5 | 77.8 [57.1; 93.2] | 86.4 | 0.346 |
| ≥ 40% | 5 | 76.1 [64.1; 86.5] | 98.2 | ||
| Treatment | PCTA | 11 | 75.8 [65.9; 84.5] | 99.0 | 0.524 |
| CABG | 11 | 80.5 [74.9; 85.5] | 96.9 |
CABG, coronary artery bypass graft surgery; CI, confidence interval; ICD, International Classification of Diseases; LVEF, Left Ventricular Ejection Fraction;N°, number of studies; NOS, Newcastle–Ottawa scale; P, p-value; PCTA, percutaneous coronary transluminal angioplasty; RTW %, return to work overall random effects pooled prevalence.
aBetween group difference.